Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study

Last updated: February 14, 2023
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Overall Status: Active - Recruiting

Phase

N/A

Condition

Catheter Complications

Soft Tissue Infections

Treatment

N/A

Clinical Study ID

NCT05729321
4880
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Epicutaneo-caval catheters (ECCs) are widely used in neonatal intensive care units (NICUs). They are small catheters inserted via superficial veins of the limbs or scalp using direct vein visualization The pathogenic microorganisms colonized inside catheters can easily form a bacterial biofilm and eventually spread with blood flow which causes bloodstream infection. Many authors have studied the antibiotic-lock therapy (ALT) in which a high-dose antibiotic solution is dripped and maintained in the catheter cavity for a certain period and can dissolve the biofilm formed on the wall to reduce the colonization of the bacteria and kill the embedded bacteria.The aim of the study is to evaluate the patency of the Epicutaneo-caval catheter after its closure for 1 hour.

Eligibility Criteria

Inclusion

Inclusion Criteria: All the Epicutaneo-caval catheter that need to be removed electively will be included inthe study -

Exclusion

Exclusion Criteria: All the Epicutaneo-caval catheters removed not electively but for infectious or mechanicalcomplications will be excluded from the study.

Study Design

Total Participants: 7
Study Start date:
September 01, 2022
Estimated Completion Date:
September 01, 2023

Connect with a study center

  • Fondazione Policlinico Gemelli IRCSS

    Roma, Itsly 00168
    Italy

    Active - Recruiting

  • FPGemelliIRCCS

    Rome, 00168
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.